147 related articles for article (PubMed ID: 18059400)
1. Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies.
Sharma R; Kacevska M; London R; Clarke SJ; Liddle C; Robertson G
Br J Cancer; 2008 Jan; 98(1):91-7. PubMed ID: 18059400
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer.
Charles KA; Rivory LP; Brown SL; Liddle C; Clarke SJ; Robertson GR
Clin Cancer Res; 2006 Dec; 12(24):7492-7. PubMed ID: 17189422
[TBL] [Abstract][Full Text] [Related]
3. Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signalling.
Kacevska M; Mahns A; Sharma R; Clarke SJ; Robertson GR; Liddle C
Pharm Res; 2013 Sep; 30(9):2270-8. PubMed ID: 23604979
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide treatment downregulates the expression of the pregnane X receptor, cyp3a11 and mdr1a genes in mouse placenta.
Chen YH; Wang JP; Wang H; Sun MF; Wei LZ; Wei W; Xu DX
Toxicology; 2005 Aug; 211(3):242-52. PubMed ID: 15869837
[TBL] [Abstract][Full Text] [Related]
5. Reversing effects of ginsenosides on LPS-induced hepatic CYP3A11/3A4 dysfunction through the pregnane X receptor.
Sun HY; Yan YJ; Li YH; Lv L
J Ethnopharmacol; 2019 Jan; 229():246-255. PubMed ID: 30342195
[TBL] [Abstract][Full Text] [Related]
6. The prominent impairment of liver/intestinal cytochrome P450 and intestinal drug transporters in sepsis-induced acute kidney injury over acute and chronic renal ischemia, a mouse model comparison.
Sukkummee W; Jittisak P; Wonganan P; Wittayalertpanya S; Chariyavilaskul P; Leelahavanichkul A
Ren Fail; 2019 Nov; 41(1):314-325. PubMed ID: 30991873
[TBL] [Abstract][Full Text] [Related]
7. Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors.
Skrobik Y; Leger C; Cossette M; Michaud V; Turgeon J
Crit Care Med; 2013 Apr; 41(4):999-1008. PubMed ID: 23385102
[TBL] [Abstract][Full Text] [Related]
8. Daikenchuto (TU-100) alters murine hepatic and intestinal drug metabolizing enzymes in an in vivo dietary model: effects of gender and withdrawal.
Nobutani K; Miyoshi J; Musch MW; Nishiyama M; Watanabe J; Kaneko A; Yamamoto M; Yoshida M; Kono T; Jeong H; Chang EB
Pharmacol Res Perspect; 2017 Oct; 5(5):. PubMed ID: 28971602
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.
Kok T; Bloks VW; Wolters H; Havinga R; Jansen PL; Staels B; Kuipers F
Biochem J; 2003 Feb; 369(Pt 3):539-47. PubMed ID: 12381268
[TBL] [Abstract][Full Text] [Related]
10. P-Glycoprotein (MDR1/ABCB1) Restricts Brain Penetration of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib, While Cytochrome P450-3A (CYP3A) Limits Its Oral Bioavailability.
van Hoppe S; Rood JJM; Buil L; Wagenaar E; Sparidans RW; Beijnen JH; Schinkel AH
Mol Pharm; 2018 Nov; 15(11):5124-5134. PubMed ID: 30247919
[TBL] [Abstract][Full Text] [Related]
11. Effect of cholecystectomy on bile acids as well as relevant enzymes and transporters in mice: Implication for pharmacokinetic changes of rifampicin.
Zhang F; Qin H; Zhao Y; Wei Y; Xi L; Rao Z; Zhang J; Ma Y; Duan Y; Wu X
Eur J Pharm Sci; 2017 Jan; 96():141-153. PubMed ID: 27637290
[TBL] [Abstract][Full Text] [Related]
12. Decreased intestinal CYP3A and P-glycoprotein activities in rats with adjuvant arthritis.
Uno S; Kawase A; Tsuji A; Tanino T; Iwaki M
Drug Metab Pharmacokinet; 2007 Aug; 22(4):313-21. PubMed ID: 17827786
[TBL] [Abstract][Full Text] [Related]
13. The transcription factor E4bp4 regulates the expression and activity of Cyp3a11 in mice.
Tong Y; Zeng P; Zhang T; Zhao M; Yu P; Wu B
Biochem Pharmacol; 2019 May; 163():215-224. PubMed ID: 30796914
[TBL] [Abstract][Full Text] [Related]
14. Increased hepatic and renal expressions of multidrug resistance-associated protein 3 in Eisai hyperbilirubinuria rats.
Kuroda M; Kobayashi Y; Tanaka Y; Itani T; Mifuji R; Araki J; Kaito M; Adachi Y
J Gastroenterol Hepatol; 2004 Feb; 19(2):146-53. PubMed ID: 14731123
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide downregulates the expressions of intestinal pregnane X receptor and cytochrome P450 3a11.
Xu DX; Wang JP; Sun MF; Chen YH; Wei W
Eur J Pharmacol; 2006 Apr; 536(1-2):162-70. PubMed ID: 16556443
[TBL] [Abstract][Full Text] [Related]
16. The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice.
Teng S; Piquette-Miller M
J Pharmacol Exp Ther; 2005 Feb; 312(2):841-8. PubMed ID: 15456840
[TBL] [Abstract][Full Text] [Related]
17. Expression of CYP3A in chronic ethanol-fed mice is mediated by endogenous pregnane X receptor ligands formed by enhanced cholesterol metabolism.
Je YT; Sim WC; Kim DG; Jung BH; Shin HS; Lee BH
Arch Toxicol; 2015 Apr; 89(4):579-89. PubMed ID: 24853400
[TBL] [Abstract][Full Text] [Related]
18. Fasting-Induced Changes in Hepatic P450 Mediated Drug Metabolism Are Largely Independent of the Constitutive Androstane Receptor CAR.
de Vries EM; Lammers LA; Achterbergh R; Klümpen HJ; Mathot RA; Boelen A; Romijn JA
PLoS One; 2016; 11(7):e0159552. PubMed ID: 27434302
[TBL] [Abstract][Full Text] [Related]
19. Gestational and pregnane X receptor-mediated regulation of placental ATP-binding cassette drug transporters in mice.
Gahir SS; Piquette-Miller M
Drug Metab Dispos; 2011 Mar; 39(3):465-71. PubMed ID: 21127142
[TBL] [Abstract][Full Text] [Related]
20. Circadian Cyp3a11 metabolism contributes to chronotoxicity of hypaconitine in mice.
Lin Y; Zhou Z; Yang Z; Gao L; Wang S; Yu P; Wu B
Chem Biol Interact; 2019 Aug; 308():288-293. PubMed ID: 31150629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]